Oncocross Revenue

Oncocross had revenue of 62.57M KRW in the quarter ending March 31, 2025, with 3.43% growth. This brings the company's revenue in the last twelve months to 1.07B, up 664.07% year-over-year. In the year 2024, Oncocross had annual revenue of 1.07B with 1,071.49% growth.

Revenue (ttm)

1.07B

Revenue Growth

+664.07%

P/S Ratio

145.51

Revenue / Employee

n/a

Employees

n/a

Market Cap

156.32B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.07B	980.68M	1,071.49%
Dec 31, 2023	91.52M	-58.72M	-39.08%
Dec 31, 2022	150.25M	50.25M	50.25%
Dec 31, 2021	100.00M	10.00M	11.11%
Dec 31, 2020	90.00M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,898.69B
Celltrion	3,662.23B
ALTEOGEN	151.65B
Yuhan	2,114.76B
SK Biopharmaceuticals	578.00B
HLB Co., Ltd.	74.64B
PharmaResearch	392.31B
LigaChem Biosciences	146.42B

Revenue Rankings